Provention Bio, Inc.
PRVB
|
$24.98
0.08%
9.1M
|
Health Technology
(0.0% 1d) (0.0% 1m) (3.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar: 2023-05-04
Market Cap: $ 2,367,626,233
http://www.proventionbio.com
Sec Filling | Patents | 19 employees
(US) Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D); PRV-015 for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 for Crohn’s disease; PRV-3279 for the treatment of lupus; and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Lebanon, NJ.
diabetes diabetic treatment
add to watch list Paper trade email alert is off
Press-releases
Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published: 2023-11-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.37%
H: 1.29%
C: 1.29%
NVO | $122.75 -1.43% 0.65% 2.7M
|
Health Technology
|
| O: 2.62%
H: 0.67%
C: 0.58%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -3.12%
H: 0.61%
C: -0.46%
VRTX | News | $393.48 0.1% 0.1% 780K
|
Health Technology
|
| O: 0.4%
H: 0.38%
C: -2.2%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: 0.0%
companies diabetes study market
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
Published: 2023-09-05 (Crawled : 11:00) - prnewswire.com
SRPT | $116.55 -1.14% -1.12% 500K
|
Health Technology
|
| O: -0.38%
H: 0.42%
C: -1.2%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 26.82%
H: 4.34%
C: -6.03%
ARQT A | $9.45 -7.81% -8.47% 2.5M
|
Health Technology
|
| O: 0.22%
H: 2.39%
C: -7.8%
SPAC Jupiter Wellness shareholders okay merger with EV maker … – Seeking Alpha
Published: 2023-05-04 (Crawled : 01:00) - spacfeed.com
MOBV | $5.0 7.2% 160K
|
n/a
|
| O: 0.1%
H: 0.0%
C: 0.0%
RCFA | $11.23 0.44% 0.0% 1.2K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.1%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
spac wellness
4 Firms Lead Regentis Biomaterials In $95M SPAC Merger – Law360
Published: 2023-05-04 (Crawled : 01:00) - spacfeed.com
RCFA | $11.23 0.44% 0.0% 1.2K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.1%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.12%
H: 0.14%
C: -0.34%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
spac
Johnson & Johnson's Kenvue IPO to command valuation of more … – Morningstar
Published: 2023-05-03 (Crawled : 00:00) - spacfeed.com
MOBV | $5.0 7.2% 160K
|
n/a
|
| O: 0.1%
H: 0.0%
C: 0.0%
RCFA | $11.23 0.44% 0.0% 1.2K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.1%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.12%
H: 0.14%
C: -0.34%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
Johnson & Johnson's Kenvue IPO to command valuation of more than $40 billion – MarketWatch
Published: 2023-05-03 (Crawled : 00:00) - spacfeed.com
RCFA | $11.23 0.44% 0.0% 1.2K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.1%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.12%
H: 0.14%
C: -0.34%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
Embark Technology: Does This Tech Stub Cigar Butt Have One Last … – Seeking Alpha
Published: 2023-05-03 (Crawled : 23:00) - spacfeed.com
MOBV | $5.0 7.2% 160K
|
n/a
|
| O: 0.1%
H: 0.0%
C: 0.0%
RCFA | $11.23 0.44% 0.0% 1.2K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.1%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
one
Avertix pumped up by SPAC deal valued at $195M – BioWorld Online
Published: 2023-05-03 (Crawled : 23:00) - spacfeed.com
MOBV | $5.0 7.2% 160K
|
n/a
|
| O: 0.1%
H: 0.0%
C: 0.0%
RCFA | $11.23 0.44% 0.0% 1.2K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.1%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
spac deal
New York Passes New Health Care Transaction Notice Requirements – Ropes & Gray LLP
Published: 2023-05-03 (Crawled : 22:00) - spacfeed.com
MOBV | $5.0 7.2% 160K
|
n/a
|
| O: 0.1%
H: 0.0%
C: 0.0%
RCFA | $11.23 0.44% 0.0% 1.2K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.1%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
health care
Kimbell Tiger Acquisition Corporation Announces Redemption of … – PR Newswire
Published: 2023-05-03 (Crawled : 22:00) - spacfeed.com
RCFA | $11.23 0.44% 0.0% 1.2K
|
n/a
|
| O: 0.19%
H: 0.0%
C: -0.1%
TGR | $10.55 0.0% 0
|
n/a
|
| O: 0.0%
H: 0.0%
C: -0.05%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
tiger redemption corporation acquisition
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Last 48 Hours Insiders Buying
ADMQ | $0.0532 -4.14% -40.18% 480K
|
|
10:30
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.41 1.34% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 930K
|
Electronic Technology
|
18:00
RMCF | $3.5501 0.57% 2.22% 18K
|
Consumer Non-Durables
|
20:10